Atlas Trials

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Clinical trial NCT06305832 · RECRUITING

Trial details

NCT number
NCT06305832
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerBiochemical Recurrence
Start date
2023-09-07
Primary completion
2028-03-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.